The numbers
Accenture is set to release its second-quarter fiscal 2026 results on March 19, and early indications show a robust performance. The consulting giant reported earnings of $2.93 per share, surpassing the Zacks Consensus Estimate by 2.5%. Total revenues reached $18 billion, exceeding expectations by 1.2% and marking an impressive 8.3% increase year-over-year.
Breaking down the revenue streams, managed services emerged as a strong performer with revenues of $9.2 billion, reflecting a 10% increase from the same quarter last year. Consulting revenues also showed resilience, climbing to $9 billion, a 7% rise year-over-year. However, not all segments fared as well; health and public service revenues totaled $3.7 billion, falling short of the consensus estimate of $3.8 billion.
In the financial services sector, Accenture reported revenues of $3.4 billion, which outpaced the Zacks Consensus Estimate of $3.3 billion. This mixed performance across different segments highlights both the strengths and challenges the company faces in a competitive market.
Accenture’s bookings for the second quarter reached $22.1 billion, a 6% increase from the previous year, indicating a positive outlook for future growth. The company’s gross margin improved to 30.3%, up 40 basis points from the year-ago quarter, showcasing effective cost management strategies.
At the end of the second quarter, Accenture reported cash and cash equivalents of $9.4 billion, providing a solid financial cushion. The company also returned value to shareholders by paying out a dividend of $1 billion during this period.
Historically, Accenture has demonstrated a decent earnings surprise track record, having surpassed the Zacks Consensus Estimate in three of the last four quarters, with only one miss. This consistency in performance has contributed to its reputation as a reliable player in the consulting and managed services industry.
As Accenture prepares to share its full earnings report, observers will be keenly watching how the company addresses the underperformance in the health and public service segment and whether it can maintain its momentum in other areas. Details remain unconfirmed, but the overall outlook appears cautiously optimistic as the company navigates the complexities of the current economic landscape.
